Usefulness of Surgical Apgar Score on Predicting Survival After Surgery for Gastric Cancer

被引:9
作者
Yamada, Takanobu [1 ,2 ]
Tsuburaya, Akira [2 ]
Hayashi, Tsutomu [1 ]
Aoyama, Toru [1 ]
Fujikawa, Hirohito [1 ]
Shirai, Junya [1 ]
Cho, Haruhiko [1 ]
Sasaki, Toshio [3 ]
Rino, Yasushi [2 ]
Masuda, Munetaka [2 ]
Yoshikawa, Takaki [1 ,2 ]
机构
[1] Kanagawa Canc Ctr, Dept Gastrointestinal Surg, Yokohama, Kanagawa, Japan
[2] Yokohama City Univ, Dept Surg, Yokohama, Kanagawa, Japan
[3] Kanagawa Canc Ctr, Dept Anesthesiol, Yokohama, Kanagawa, Japan
关键词
RANDOMIZED CONTROLLED-TRIAL; NODAL DISSECTION; COMPLICATIONS; GASTRECTOMY; IMPACT; ANESTHESIA; MORTALITY; PHASE-3;
D O I
10.1245/s10434-016-5525-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. Complete surgical resection is essential for a cure for most gastric cancer. Recently it was reported that surgical Apgar score (SAS) can predict postoperative complication and that postoperative complication is associated with poor long-term survival. The aim of this study is to assess whether SAS can predict overall survival (OS) after surgery for gastric cancer. Methods. We retrospectively compared clinicopathological characteristics and survival between high and low SAS score groups in patients who underwent gastrectomy for gastric cancer. Results. Low-scored SAS group (group L) was significantly more common among ASA-PS 2, open approach, total gastrectomy, D2 lymph node dissection, postoperative complication grade 2-4, deep tumor invasion, lymph node metastases, and advanced pathological TNM stage than high-scored SAS group (group H). The 5-year OS of group H and group L were 81.6 and 55.9 %, respectively (p < .001); OS of group L tended to be poorer than that of group H in stage III patients (p = .060) and in stage IV patients (p < .001). In multivariate analysis, pathological stage and SAS were identified as independent predictors for OS. Conclusions. SAS is useful for predicting survival after surgery for gastric cancer.
引用
收藏
页码:S757 / S763
页数:7
相关论文
共 25 条
[1]  
[Anonymous], 2016, GLOBOCAN 2012 V1 0 C
[2]   Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial [J].
Bang, Yung-Jue ;
Kim, Young-Woo ;
Yang, Han-Kwang ;
Chung, Hyun Cheol ;
Park, Young-Kyu ;
Lee, Kyung Hee ;
Lee, Keun-Wook ;
Kim, Yong Ho ;
Noh, Sang-Ik ;
Cho, Jae Yong ;
Mok, Young Jae ;
Kim, Yeul Hong ;
Ji, Jiafu ;
Yeh, Ta-Sen ;
Button, Peter ;
Sirzen, Florin ;
Noh, Sung Hoon .
LANCET, 2012, 379 (9813) :315-321
[3]  
Bonenkamp JJ, 1990, NEW ENGL J MED, V340, P908
[4]   Postoperative morbidity and mortality after D-1 and D-2 resections for gastric cancer: Preliminary results of the MRC randomised controlled surgical trial [J].
Cuschieri, A ;
Fayers, P ;
Fielding, J ;
Craven, J ;
Bancewicz, J ;
Joypaul, V ;
Cook, P .
LANCET, 1996, 347 (9007) :995-999
[5]   Classification of surgical complications - A new proposal with evaluation in a cohort of 6336 patients and results of a survey [J].
Dindo, D ;
Demartines, N ;
Clavien, PA .
ANNALS OF SURGERY, 2004, 240 (02) :205-213
[6]   Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial [J].
Fujitani, Kazumasa ;
Yang, Han-Kwang ;
Mizusawa, Junki ;
Kim, Young-Woo ;
Terashima, Masanori ;
Han, Sang-Uk ;
Iwasaki, Yoshiaki ;
Hyung, Woo Jin ;
Takagane, Akinori ;
Park, Do Joong ;
Yoshikawa, Takaki ;
Hahn, Seokyung ;
Nakamura, Kenichi ;
Park, Cho Hyun ;
Kurokawa, Yukinori ;
Bang, Yung-Jue ;
Park, Byung Joo ;
Sasako, Mitsuru ;
Tsujinaka, Toshimasa .
LANCET ONCOLOGY, 2016, 17 (03) :309-318
[7]   An Apgar score for surgery [J].
Gawande, Atul A. ;
Kwaan, Mary R. ;
Regenbogen, Scott E. ;
Lipsitz, Stuart A. ;
Zinner, Michael J. .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2007, 204 (02) :201-208
[8]   Impact of infectious complications on gastric cancer recurrence [J].
Hayashi, Tsutomu ;
Yoshikawa, Takaki ;
Aoyama, Toru ;
Hasegawa, Shinichi ;
Yamada, Takanobu ;
Tsuchida, Kazuhito ;
Fujikawa, Hirohito ;
Sato, Tsutomu ;
Ogata, Takashi ;
Cho, Haruhiko ;
Oshima, Takashi ;
Rino, Yasushi ;
Masuda, Munetaka .
GASTRIC CANCER, 2015, 18 (02) :368-374
[9]   Surgical outcome measurement for a global patient population: Validation of the Surgical Apgar Score in 8 countries [J].
Haynes, Alex B. ;
Regenbogen, Scott E. ;
Weiser, Thomas G. ;
Lipsitz, Stuart R. ;
Dziekan, Gerald ;
Berry, William R. ;
Gawande, Atul A. .
SURGERY, 2011, 149 (04) :519-524
[10]  
Japanese Gastric Cancer Association, 2011, GASTRIC CANCER, V14, P113, DOI [DOI 10.1007/S10120-011-0042-4, 10.1007/s10120-011-0042-4, DOI 10.1007/S10120-011-0042-4]]